Skip to search formSkip to main contentSkip to account menu

Reifenstein Syndrome

Known as: gilbert dreyfus syndrome, Androgen-Insensitivity Syndromes, Partial, Androgen-Insensitivity Syndrome, Partial 
A disorder also known as partial androgen insensitivity syndrome (PAIS). These patients exhibit partial resistance to androgenic and metabolic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
5-Fluorouracil (5-FU) is a potent antimetabolite used for chemotherapy of gastrointestinal (GI), breast, and head and neck… 
Highly Cited
1999
Highly Cited
1999
PURPOSE To compare the efficacy of bicalutamide monotherapy to maximal androgen blockade (MAB) in the treatment of advanced… 
Highly Cited
1999
Highly Cited
1999
In order to explore the mechanism of obesity in long‐term survivors of childhood leukaemia, fat mass, lean body mass and serum… 
Highly Cited
1997
Highly Cited
1997
The current version of the androgen receptor (AR) gene mutations database is described. The total number of reported mutations… 
Highly Cited
1993
Highly Cited
1993
In order to dissect the functions of laminin A in vivo, we have undertaken a molecular and genetic characterization of the… 
Highly Cited
1977
Highly Cited
1977
We investigated eight patients with the Reifenstein syndrome to define the hormonal basis for this condition. The patients had… 
Highly Cited
1968
Highly Cited
1968
Cerebral maturation during the last three months of fetal life brings about constant modification of muscle tone and of certain…